Key result
A 68-year-old male developed a massive, fatal spontaneous retroperitoneal hematoma 8 days after starting double antiplatelet and anticoagulant therapy for a non-ST elevation myocardial infarction.
Case Report (n=1)
Highlights the severe and potentially fatal risk of spontaneous retroperitoneal hematoma in patients receiving aggressive antithrombotic therapy for acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Fatal spontaneous retroperitoneal hematoma remains a rare risk with triple antithrombotic therapy post-NSTEMI; this case leaves open optimal regimen intensity in elderly patients.
Retroperitoneal spontaneous hematoma is a serious condition, sometimes fatal. It occurs in association with anticoagulant therapy, unrelated to any trauma, surgery, invasive procedures or aortic aneurysm.A 68-year-old male patient is admitted for a non ST elevation myocardial infarction. He has a history of ischemic dilated cardiomyopathy with severe systolic dysfunction and atrial fibrillation. He is started on double antiplatelet therapy, anticoagulation, statin, beta blocker, ACE, and iv diuretic. Eight days later he suffers a syncope and the clinical examination reveals a large tender abdominal mass. The computed tomography examination shows a massive retroperitoneal hematoma. Although the antiplatelet and anticoagulant therapy is discontinued, the volume resuscitation (with crystalloids and packed red blood cells) is initiated and vasoconstrictor drugs are used, his condition continues to deteriorate. He is taken to the operation room for emergency laparotomy and the hematoma is evacuated. Although his clinical status improved and he remained hemodinamically stable, he suffers a cardiac arrest 27 days later and the resuscitation maneuvers are unsuccessful.
No takes yet. Share an insight, caveat, or question.
Popescu et al. (2015) conducted a case report in Non ST elevation myocardial infarction and retroperitoneal spontaneous hematoma (n=1). Antithrombotic treatment (double antiplatelet therapy and anticoagulation) was evaluated on Retroperitoneal spontaneous hematoma and clinical outcome. A 68-year-old male developed a massive, fatal spontaneous retroperitoneal hematoma 8 days after starting double antiplatelet and anticoagulant therapy for a non-ST elevation myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: